 |
|
|
Thrombus Aspiration Before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows Main Category: Cardiovascular / Cardiology Article Date: 14 May 2008 - 3:00 PDT Medtronic, Inc. Date: Sat, 17 May 2008 17:57:31 GMT Studies Presented At Spine Arthroplasty Society Annual Meeting Find... ArthroCare Corp. , a leader in developing state-of-the-art, minimally invasive surgical products, announced that a study demonstrating the effectiveness of plasma disc decompression for treating patients with ... Date: Sat, 17 May 2008 09:53:12 GMT Spirit III Results Reaffirm Strong Performance Of Boston Scientific... Boston Scientific Corporation welcomed two-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety and efficacy of the market-leading TAXUS Express2 ... Date: Sat, 17 May 2008 01:48:09 GMT International Endeavor Registry Reports Safety and Performance of... "Registries generally enroll more challenging 'real-world' patients than randomized trials" MINNEAPOLIS & BARCELONA, Spain-- --May 15, 2008 - New data presented today at EuroPCR reports extensive experience on the safety and performance of Medtronic's Endeavor Zotarolimus-Eluting Coronary Stent in ... via Med Ad News Date: Fri, 16 May 2008 17:43:30 GMT Uroplasty To Highlight Urgent PC System At American Urological Association 2008 Annual Meeting Main Category: Urology / Nephrology Also Included In: Medical Devices ; Conferences Article Date: 14 May 2008 - 0:00 PDT Uroplasty, Inc. via Medical News Today Date: Fri, 16 May 2008 09:33:13 GMT Heparin Producer To Raise Prices APP Pharmaceuticals Inc., Thursday said it was raising the price of its blood thinner heparin in the wake of an ingredient shortage in China. via The Post Chronicle Date: Fri, 16 May 2008 01:22:39 GMT CardioDynamics Announces Significant ICG Study with Nearly Three... "These are impressive, real-world results, nearly three times the national average, across a 65-plus multi-specialty physician group practice" Study results were reported from a 65 physician primary care and cardiology group practice and demonstrated an impressive 102% improvement in blood pressure control rates, with control rates improving from 42% ... via Rehab Management Date: Thu, 15 May 2008 21:08:18 GMT Endeavor II Four-Year Results Demonstrate Long-Term Safety... "As the duration of follow-up in ENDEAVOR II grows, so too does our confidence in the enduring safety and effectiveness of the Endeavor stent" Main Category: Cardiovascular / Cardiology Article Date: 15 May 2008 - 2:00 PDT Today at EuroPCR, Medtronic, Inc. via Medical News Today Date: Thu, 15 May 2008 16:49:23 GMT Medtronic Announces FDA Approval Of New Vision 3D Wireless Implantable Cardiac Devices "This also gives us insight into key trend data to help better manage the patient's condition, rather than simply inform us how the implanted device is operating." Leading into Heart Rhythm 2008, the pre-eminent worldwide gathering of cardiologists specializing in electrophysiology, Medtronic, Inc. via MediLexicon Date: Thu, 15 May 2008 12:28:15 GMT New Heparin Safety Concerns Arise "I wouldn't be surprised if it has already happened." Efforts to make the blood thinner heparin safer -- and to replace supplies that were depleted by a massive recall earlier this year -- have meant unintended and fresh safety concerns for hospitals, heart ... via AMNY Date: Thu, 15 May 2008 08:05:30 GMT Copyright 2008, Topix |
|
|
||||
|
||||
|
||||
|
| Home | Get Started | Buy Equipment | Sell Equipment | My MedPlanet Privacy Policy | Contact MedPlanet | Help | Links | News Copyright © 2007, MedPlanet.com SITE DESIGN by NYCwebdesign.net |